NAD/NADP Index Test

Your body runs on a pair of molecular workhorses that almost no standard blood test ever checks. NAD (nicotinamide adenine dinucleotide) fuels the chemical reactions that turn food into energy, repair damaged DNA, and regulate how your genes respond to stress. Its close relative NADP (nicotinamide adenine dinucleotide phosphate) powers your antioxidant defense systems and builds essential molecules like fatty acids and cholesterol. The NAD/NADP Index captures the balance between these two pools, offering a window into whether your cellular machinery is keeping pace with the demands placed on it.

What makes this ratio interesting from a longevity perspective is that NAD levels decline steadily as you age, across virtually every tissue that has been studied. That decline is linked to the metabolic dysfunction, cardiovascular disease, and neurodegeneration that characterize aging itself. By measuring both NAD and NADP together, you get a more complete picture than either molecule alone provides.

What This Index Actually Measures

NAD and NADP are small molecules (not proteins or hormones) that belong to a family called pyridine nucleotide coenzymes. They exist in two forms: an oxidized form (NAD+, NADP+) and a reduced form (NADH, NADPH). The difference between them is a single phosphate group, but their jobs in your body are strikingly different.

NAD+ is the workhorse of energy metabolism. It picks up electrons during the breakdown of glucose and fats, then hands them off to your mitochondria to generate ATP, your cells' energy currency. But NAD+ also moonlights as a raw material for signaling enzymes called sirtuins (which regulate gene expression and stress resistance) and PARPs (which repair DNA damage). Every time one of these enzymes fires, it consumes an NAD+ molecule, meaning your supply is constantly being drained.

NADP+, in its reduced form NADPH, does something entirely different. It powers your glutathione and thioredoxin systems, which are your primary defenses against oxidative damage. It also supplies the chemical fuel for building fatty acids and other essential molecules. Your body keeps NADPH levels high relative to NADP+ to ensure these protective systems stay loaded and ready.

The NAD/NADP Index, historically used as a "niacin index" measured in red blood cells, captures the ratio between these two pools. An index below 1.0 has been proposed as a marker for niacin (vitamin B3) deficiency, since NAD levels drop by roughly 70% during niacin depletion while NADP levels stay relatively unchanged.

The Age-Related NAD Decline

NAD+ levels fall progressively with age across multiple tissues, including liver, skin, muscle, pancreas, and fat. This decline is now considered a hallmark of biological aging. In human skin, NAD+ shows a strong negative correlation with age in both men and women. Plasma measurements confirm that NAD+ and NADP+ concentrations drop significantly between your 20s and your 80s, while the reduced forms (NADH, NADPH) tend to rise, shifting the overall redox balance.

Two enzymes bear much of the blame. CD38, which ramps up with chronic inflammation, chews through NAD+ at an accelerating rate as you get older. PARPs, activated by the DNA damage that accumulates over a lifetime, consume NAD+ every time they attempt a repair. Together, these consumption pathways outstrip your body's ability to make new NAD+, creating a widening deficit that touches every organ system.

Sex and Age Differences

Men and women handle NAD differently, and those differences shift with age. In a study of over 1,500 adults from the Jidong community in China, men had significantly higher whole blood NAD than women (34.5 vs. 31.3 micromol/L). A separate fingerstick blood assay study confirmed that males tend to have higher NAD than females before age 50.

The aging trajectory also differs by sex. Males showed declining NAD with age, particularly after 60, while females showed no significant age-related trend in the same population. Plasma NAD+/NADH ratios tell yet another story: women had higher ratios than men (median 1.33 vs. 1.09), a difference that depends on age. These sex-specific patterns mean that reference ranges for the NAD/NADP Index should ideally account for both sex and age.

Metabolic Disease Connections

The relationship between NAD and metabolic disease is not straightforward. In the Jidong community study of 1,394 participants (mean age 43.2 years), researchers divided whole blood NAD into four groups. Compared to those with the lowest NAD levels (29.4 micromol/L or below), people in the highest group were about 3 times as likely to have metabolic disease (adjusted odds ratio 3.01). The association grew stronger with the number of metabolic problems present: those with 3 to 6 metabolic components had roughly 4.3 times the odds.

This finding is counterintuitive. If NAD declines with aging and disease, why would higher levels be associated with more metabolic problems? The researchers attributed this to a compensatory mechanism, where the body ramps up NAD production in response to metabolic stress. This pattern is a reminder that a single cross-sectional reading can be misleading, and that the trajectory of your NAD levels over time matters more than any isolated number.

Cardiovascular and Neurological Links

NAD depletion has been implicated in heart disease, heart failure, hypertension, and atherosclerosis, where it contributes to blood vessel dysfunction and impaired energy production in heart muscle cells. Blood NAD levels were found to be significantly lower in cardiac patients with heart failure (13 micromol/L) compared to healthy controls (18 micromol/L) in one clinical study.

The brain is equally vulnerable. Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions show NAD depletion that impairs neuronal energy metabolism and accelerates oxidative damage. Patients with demyelinating neurological diseases had similarly depressed NAD (14 micromol/L). The NAD/NADP Index provides context here because NADPH is the molecule that recharges your brain's primary antioxidant systems. If the ratio shifts, it may signal that both energy production and antioxidant defense are compromised simultaneously.

Kidney Function and Acute Illness

Your kidneys are among the most NAD-sensitive organs. In chronic kidney disease, both NAD and NADH content decline in kidney tissue, and key enzymes responsible for making NAD (QPRT, NMNAT1, NMNAT3) are significantly suppressed. Acute kidney injury causes an even sharper NAD drop by impairing the body's ability to synthesize NAD from scratch.

Acute infections also disrupt NAD metabolism. In hospitalized COVID-19 patients, NAD turnover increased substantially, with the body simultaneously ramping up both production and degradation pathways. Circulating NAD+ showed a negative correlation with C-reactive protein (a marker of inflammation), suggesting that active inflammation draws down NAD reserves.

Reference Ranges

There are no universally standardized clinical reference ranges for the NAD/NADP Index, and values vary significantly depending on the assay method, sample type, and laboratory. That said, the available research provides useful orientation for interpreting your results.

These tiers are drawn from published research on erythrocyte niacin coenzymes. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend. For context, whole blood NAD in a general population averaged 33.0 plus or minus 5.5 micromol/L, with men averaging about 3 micromol/L higher than women.

Why One Reading Is Not Enough

NAD metabolism is one of the most dynamic systems in your body. The molecule has a half-life measured in minutes in some tissues, with your cells constantly building and consuming it. A single blood draw captures a snapshot of a process that fluctuates with your recent diet, exercise, stress, inflammation, and even the time of day in certain tissues. One reassuring finding is that blood NAD and NADP concentrations do not appear to fluctuate with time of day, even though urinary NAD metabolites do. This means blood-based testing avoids the worst circadian confounding.

Individual baseline NAD levels do show long-term stability over periods of 100 days or more when measured consistently. This means tracking is feasible and meaningful. Get a baseline measurement, retest in 3 to 6 months if you are making dietary or supplement changes, and then monitor at least annually. What you are looking for is the direction and speed of change, not whether a single number crosses a threshold. A downward trend in the NAD/NADP Index over serial readings, even if still above 1.0, could signal accelerating NAD consumption that merits investigation.

Why a Single Reading Can Fool You

A meta-analysis of NAD(P)(H) measurements across mammalian tissues found significant variability between and within measurement methods, making cross-lab comparisons unreliable. If you switch labs or assay platforms, expect your numbers to shift for purely technical reasons.

Acute exercise increases NAD+ in immune cells, so a blood draw taken shortly after a hard workout may not represent your resting baseline. Acute illness and active infections increase NAD turnover and can temporarily depress circulating levels. High protein intake has been associated with lower plasma NAD+, so your recent diet matters. Kidney disease alters NAD metabolism substantially and will affect how your body both produces and clears these molecules.

Sample handling also matters more than usual with this test. Extracellular NAD+ in plasma is roughly 500 times lower than intracellular NAD+, so even minor cell breakage during the blood draw can contaminate the reading. Prolonged centrifugation and aggressive braking during sample processing have been shown to affect results. If your value seems unexpectedly high or low, consider whether pre-analytical factors could be responsible before drawing conclusions.